Please use this identifier to cite or link to this item: https://hdl.handle.net/1/2277
Title: Targeted Therapies for Microvascular Disease
Authors: Bland, Adam ;Chuah, Eunice ;Meere, William ;Ford, Tom 
Affliation: Central Coast Local Health District
Gosford Hospital
Issue Date: Jan-2023
Source: 12(1):131-139
Journal title: Interventional Cardiology Clinics
Department: Cardiology
Abstract: Coronary microvascular dysfunction (CMD) is a common cause of ischemia but no obstructive coronary artery disease that results in an inability of the coronary microvasculature to meet myocardial oxygen demand. CMD is challenging to diagnose and manage due to a lack of mechanistic research and targeted therapy. Recent evidence suggests we can improved patient outcomes by stratifying antianginal therapies according to the diagnosis revealed by invasive assessment of the coronary microcirculation. This review article appraises the evidence for management of CMD, which includes treatment of cardiovascular risk, antianginal therapy and therapy for atherosclerosis.
URI: https://hdl.handle.net/1/2277
DOI: 10.1016/j.iccl.2022.09.011
Pubmed: https://pubmed.ncbi.nlm.nih.gov/36372457/
Publicaton type: Journal Article
Keywords: Cardiology
Cardiovascular Disease
Heart Disease
Appears in Collections:Cardiology

Show full item record

Page view(s)

20
checked on Feb 7, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.